AngioDynamics (ANGO) Tops Q2 EPS by 10c, Beats on Revenue; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.00, $0.10 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $79.4 million versus the consensus estimate of $76.3 million.
GUIDANCE:
AngioDynamics sees FY2026 EPS of ($0.33)-($0.23), versus the consensus of ($0.33). AngioDynamics sees FY2026 revenue of $312-314 million, versus the consensus of $310 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pursuit Attractions and Hospitality, Inc. (PRSU) Misses Q3 EPS by 601c ; Offers Guidance
- Envista Holdings Corp. (NVST) Tops Q3 EPS by 4c, Beats on Revenue; Offers FY26 Guidance
- Texas Pacific Land Trust (TPL) Tops Q3 EPS by 6c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
